Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
The summary for the Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44): The purpose of this initiative is to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
Federal Grant Title: | Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-17-035 |
Type of Funding: | Grant |
CFDA Numbers: | 93.286, 93.350, 93.855, 93.856 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | September 5th, 2019 |
Original Application Deadline: | September 5th, 2019 |
Posted Date: | October 27th, 2016 |
Creation Date: | October 27th, 2016 |
Archive Date: | October 6th, 2019 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | October 27th, 2016 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-17-035.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Opt...
- • Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historic...
- • Understanding and Mitigating Health Disparities experienced by People with Disabilities ca...
- • National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Op...
- • Research on Bioethical Issues Related to Bionic and Robotic Device Development and Transla...
- • Exploratory Grants (P20) for NIBIB Quantum Projects
- • Nibib Research Supplements to Promote Clinical Resident Research Experiences
- • Innovation in Molecular Imaging Probes
- More Grants from the National Institutes of Health
- • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
- • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...